Apogee Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Apogee Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Apogee Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Apogee Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $45M | 1.1M | 39.73 |
| 2025-03-31 | $36M | 963k | 37.36 |
| 2024-12-31 | $1.7M | 37k | 45.30 |
| 2024-09-30 | $1.7M | 30k | 58.74 |
| 2024-06-30 | $1.1M | 28k | 39.35 |
| 2024-03-31 | $1.6M | 24k | 66.45 |
| 2023-12-31 | $644k | 23k | 27.94 |
| 2023-09-30 | $282k | 13k | 21.30 |